Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston C Tse

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Protocols in Nucleic Acid Chemistry|April 23, 2008
A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinityWinston C Tse, Dale L Boger
Accounts of Chemical Research|January 21, 2004
A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinityWinston C Tse, Dale L Boger
Chemistry & Biology|December 22, 2004
Sequence-selective DNA recognition: natural products and nature's lessonsWinston C Tse, Dale L Boger
Bioorganic & Medicinal Chemistry|September 18, 2003
Comprehensive high-resolution analysis of hairpin polyamides utilizing a fluorescent intercalator displacement (FID) assayWinston C Tse, Takahiro Ishii, Dale L Boger
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
High-resolution assessment of protein DNA binding affinity and selectivity utilizing a fluorescent intercalator displacement (FID) assayYoung-Wan Ham, Winston C Tse, Dale L Boger
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Determination of binding affinities of triplex forming oligonucleotides using a fluorescent intercalator displacement (FID) assayBryan K S Yeung, Winston C Tse, Dale L Boger
Molecular Pharmaceutics|November 2, 2023
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral AgentRaju Subramanian, Jennifer Tang, Jim Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance PathwayJim Zheng, Bing Lu, Gavin Carr, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Protocols in Nucleic Acid Chemistry|April 23, 2008
A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinityWinston C Tse, Dale L Boger
Accounts of Chemical Research|January 21, 2004
A fluorescent intercalator displacement assay for establishing DNA binding selectivity and affinityWinston C Tse, Dale L Boger
Chemistry & Biology|December 22, 2004
Sequence-selective DNA recognition: natural products and nature's lessonsWinston C Tse, Dale L Boger
Bioorganic & Medicinal Chemistry|September 18, 2003
Comprehensive high-resolution analysis of hairpin polyamides utilizing a fluorescent intercalator displacement (FID) assayWinston C Tse, Takahiro Ishii, Dale L Boger
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
High-resolution assessment of protein DNA binding affinity and selectivity utilizing a fluorescent intercalator displacement (FID) assayYoung-Wan Ham, Winston C Tse, Dale L Boger
Bioorganic & Medicinal Chemistry Letters|October 14, 2003
Determination of binding affinities of triplex forming oligonucleotides using a fluorescent intercalator displacement (FID) assayBryan K S Yeung, Winston C Tse, Dale L Boger
Molecular Pharmaceutics|November 2, 2023
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral AgentRaju Subramanian, Jennifer Tang, Jim Zheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 8, 2024
Lenacapavir Exhibits Atropisomerism-Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance PathwayJim Zheng, Bing Lu, Gavin Carr, et al.
Nature Medicine|September 11, 2019
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse modelStephen R Yant, Andrew Mulato, Derek Hansen, et al.
Nature|July 3, 2020
Clinical targeting of HIV capsid protein with a long-acting small moleculeJohn O Link, Martin S Rhee, Winston C Tse, et al.
Pageof 1